Symbols / NSPR Stock $1.17 -2.50% InspireMD, Inc.

Healthcare • Medical Devices • United States • NCM
NSPR (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Marvin L. Slosman
Exch · Country NCM · United States
Market Cap 54.86M
Enterprise Value 3.84M
Income -48.79M
Sales 8.98M
FCF (ttm) -18.73M
Book/sh 1.27
Cash/sh 1.16
Employees 127
Insider 10d —
IPO Apr 12, 2011
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -1.92
PEG —
P/S 6.11
P/B 0.92
P/C —
EV/EBITDA -0.08
EV/Sales 0.43
Quick Ratio 5.30
Current Ratio 5.74
Debt/Eq 5.96
LT Debt/Eq —
EPS (ttm) -0.70
EPS next Y -0.61
EPS Growth —
Revenue Growth 61.60%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-04
Earnings (prior) 2026-05-04
ROA -53.37%
ROE -106.89%
ROIC —
Gross Margin 29.50%
Oper. Margin -3.84%
Profit Margin 0.00%
Shs Outstand 46.89M
Shs Float 27.09M
Insider Own 19.86%
Instit Own 49.32%
Short Float 0.07%
Short Ratio 0.55
Short Interest 28.76K
52W High 2.93
vs 52W High -60.07%
52W Low 1.02
vs 52W Low 14.71%
Beta 0.82
Impl. Vol. 37.22%
Rel Volume 1.21
Avg Volume 257.29K
Volume 311.31K
Target (mean) $3.67
Tgt Median $4.00
Tgt Low $3.00
Tgt High $4.00
# Analysts 3
Recom Buy
Prev Close $1.20
Price $1.17
Change -2.50%
About

InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$3.67
Mean price target
2. Current target
$1.17
Latest analyst target
3. DCF / Fair value
$-7.19
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.17
Low
$3.00
High
$4.00
Mean
$3.67

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-05 reit Piper Sandler Overweight → Overweight $3
2025-05-12 main Piper Sandler Overweight → Overweight $4
2024-12-11 init Lake Street — → Buy $5
2023-11-02 main Piper Sandler Overweight → Overweight $5
2023-06-12 init Piper Sandler — → Overweight $3
2023-05-17 main National Alliance Securities — → Buy $5
2023-03-31 main Alliance Global Partners — → Buy $5
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-05-11 STUKA PAUL Director — 75,626 $1.16 $88,026
2026-05-07 ROUBIN GARY S Director — 90,000 $1.18 $106,200
2026-05-07 WARD SCOTT RAYMOND Director — 89,250 $1.15 $102,638
2026-05-07 STUKA PAUL Director — 7,895 $1.12 $9,034
2026-02-02 GLEASON SHANE THOMAS Officer — 61,194 $1.57 $99,331
2026-01-14 BERMAN MICHAEL Director — 88,053 $0.00 $0
2026-01-14 COHEN RAYMOND W Director — 44,030 $0.00 $0
2026-01-14 SLOSMAN MARVIN Chief Executive Officer — 1,114,792 $0.00 $0
2026-01-14 ROUBIN GARY S Director — 88,053 $0.00 $0
2026-01-14 WARD SCOTT RAYMOND Director — 88,053 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
8.98
+28.11%
7.01
+12.96%
6.21
+20.00%
5.17
Operating Revenue
8.98
+28.11%
7.01
+12.96%
6.21
+20.00%
5.17
Cost Of Revenue
6.33
+15.03%
5.50
+25.13%
4.40
+8.49%
4.05
Reconciled Cost Of Revenue
6.33
+15.03%
5.50
+25.13%
4.40
+8.49%
4.05
Gross Profit
2.65
+75.90%
1.51
-16.66%
1.81
+61.77%
1.12
Operating Expense
52.26
+49.28%
35.01
+52.54%
22.95
+15.73%
19.83
Research And Development
15.00
+10.04%
13.63
+70.83%
7.98
+2.19%
7.81
Selling General And Administration
37.26
+74.32%
21.38
+42.80%
14.97
+24.53%
12.02
Selling And Marketing Expense
16.55
+172.75%
6.07
+57.02%
3.87
+5.49%
3.66
General And Administrative Expense
20.71
+35.29%
15.31
+37.84%
11.10
+32.89%
8.36
Other Gand A
20.71
+35.29%
15.31
+37.84%
11.10
+32.89%
8.36
Total Expenses
58.59
+44.63%
40.51
+48.14%
27.35
+14.50%
23.88
Operating Income
-49.61
-48.09%
-33.50
-58.46%
-21.14
-12.99%
-18.71
Total Operating Income As Reported
-49.61
-48.09%
-33.50
-58.46%
-21.14
-12.99%
-18.71
EBITDA
-49.14
-47.90%
-33.22
-58.88%
-20.91
-12.88%
-18.52
Normalized EBITDA
-49.14
-47.90%
-33.22
-58.88%
-20.91
-12.88%
-18.52
Reconciled Depreciation
0.48
+70.00%
0.28
+20.69%
0.23
+23.40%
0.19
EBIT
-49.61
-48.09%
-33.50
-58.46%
-21.14
-12.99%
-18.71
Net Income
-48.79
-52.43%
-32.01
-60.70%
-19.92
-7.71%
-18.49
Pretax Income
-48.72
-52.52%
-31.95
-60.93%
-19.85
-7.52%
-18.46
Net Non Operating Interest Income Expense
0.89
-42.77%
1.56
+20.51%
1.29
+416.80%
0.25
Interest Expense Non Operating
—
—
—
—
Net Interest Income
0.89
-42.77%
1.56
+20.51%
1.29
+416.80%
0.25
Interest Expense
—
—
—
—
Interest Income Non Operating
0.89
-42.77%
1.56
+20.51%
1.29
+416.80%
0.25
Interest Income
0.89
-42.77%
1.56
+20.51%
1.29
+416.80%
0.25
Tax Provision
0.06
+6.78%
0.06
-9.23%
0.07
+132.14%
0.03
Tax Rate For Calcs
0.00
-100.00%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-48.79
-52.43%
-32.01
-60.70%
-19.92
-7.71%
-18.49
Net Income From Continuing Operation Net Minority Interest
-48.79
-52.43%
-32.01
-60.70%
-19.92
-7.71%
-18.49
Net Income From Continuing And Discontinued Operation
-48.79
-52.43%
-32.01
-60.70%
-19.92
-7.71%
-18.49
Net Income Continuous Operations
-48.79
-52.43%
-32.01
-60.70%
-19.92
-7.71%
-18.49
Normalized Income
-48.79
-52.43%
-32.01
-60.70%
-19.92
-7.71%
-18.49
Net Income Common Stockholders
-48.79
-52.43%
-32.01
-60.70%
-19.92
-7.71%
-18.49
Diluted EPS
—
-0.76
+7.32%
-0.82
+65.11%
-2.35
Basic EPS
—
-0.76
+7.32%
-0.82
+65.11%
-2.35
Basic Average Shares
—
41.93
+72.77%
24.27
+208.29%
7.87
Diluted Average Shares
—
41.93
+72.77%
24.27
+208.29%
7.87
Diluted NI Availto Com Stockholders
-48.79
-52.43%
-32.01
-60.70%
-19.92
-7.71%
-18.49
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
69.40
+48.28%
46.81
-1.75%
47.64
+93.25%
24.65
Current Assets
61.47
+51.70%
40.52
-8.24%
44.16
+107.07%
21.33
Cash Cash Equivalents And Short Term Investments
54.21
+56.51%
34.64
-11.24%
39.02
+119.19%
17.80
Cash And Cash Equivalents
8.94
-52.74%
18.92
+96.22%
9.64
+108.12%
4.63
Other Short Term Investments
45.27
+187.97%
15.72
-46.50%
29.38
+123.09%
13.17
Receivables
2.57
+13.93%
2.25
-8.08%
2.45
+96.63%
1.25
Accounts Receivable
2.17
+37.91%
1.57
-12.86%
1.80
+74.47%
1.03
Other Receivables
0.40
-41.35%
0.68
+5.25%
0.65
+204.23%
0.21
Inventory
3.40
+32.14%
2.57
+22.03%
2.11
+29.92%
1.62
Raw Materials
2.11
+10.45%
1.91
+43.48%
1.33
+43.13%
0.93
Work In Process
0.93
+45.77%
0.64
+13.52%
0.56
+10.20%
0.51
Finished Goods
0.35
+1855.56%
0.02
-91.43%
0.21
+17.32%
0.18
Prepaid Assets
1.30
+22.26%
1.06
+83.39%
0.58
-11.76%
0.66
Total Non Current Assets
7.93
+26.20%
6.29
+80.42%
3.48
+4.72%
3.33
Net PPE
6.34
+34.05%
4.73
+86.77%
2.53
+2.51%
2.47
Gross PPE
9.07
+28.59%
7.05
+54.19%
4.57
+4.43%
4.38
Accumulated Depreciation
-2.73
-17.46%
-2.32
-13.73%
-2.04
-6.92%
-1.91
Machinery Furniture Equipment
5.22
+36.34%
3.83
+61.20%
2.38
+1.93%
2.33
Other Properties
2.76
+16.86%
2.36
+60.22%
1.47
-5.21%
1.55
Leases
1.09
+26.25%
0.86
+18.92%
0.72
+46.56%
0.49
Non Current Prepaid Assets
0.44
+3.76%
0.43
0.00
—
Total Liabilities Net Minority Interest
14.20
+32.48%
10.72
+31.68%
8.14
+12.15%
7.26
Current Liabilities
10.71
+39.52%
7.68
+27.54%
6.02
+18.74%
5.07
Payables And Accrued Expenses
4.72
+26.84%
3.72
+13.65%
3.27
+17.05%
2.80
Payables
1.59
+5.43%
1.51
+33.66%
1.13
+43.09%
0.79
Accounts Payable
1.25
+0.08%
1.25
+33.55%
0.94
+42.49%
0.66
Other Payable
0.34
+31.76%
0.26
+34.21%
0.19
+46.15%
0.13
Current Accrued Expenses
3.13
+41.44%
2.21
+3.12%
2.15
+6.82%
2.01
Employee Benefits
1.27
+1.60%
1.25
+15.04%
1.08
+8.94%
0.99
Pensionand Other Post Retirement Benefit Plans Current
4.92
+44.26%
3.41
+56.03%
2.19
+18.08%
1.85
Current Debt And Capital Lease Obligation
1.07
+96.68%
0.54
-2.69%
0.56
+32.94%
0.42
Current Capital Lease Obligation
1.07
+96.68%
0.54
-2.69%
0.56
+32.94%
0.42
Total Non Current Liabilities Net Minority Interest
3.49
+14.72%
3.04
+43.40%
2.12
-3.11%
2.19
Long Term Debt And Capital Lease Obligation
2.22
+23.83%
1.80
+73.03%
1.04
-13.14%
1.20
Long Term Capital Lease Obligation
2.22
+23.83%
1.80
+73.03%
1.04
-13.14%
1.20
Defined Pension Benefit
1.15
+1.77%
1.13
+18.72%
0.95
+11.10%
0.86
Non Current Pension And Other Postretirement Benefit Plans
1.27
+1.60%
1.25
+15.04%
1.08
+8.94%
0.99
Stockholders Equity
55.20
+52.97%
36.09
-8.65%
39.50
+127.11%
17.39
Common Stock Equity
55.20
+52.97%
36.09
-8.65%
39.50
+127.11%
17.39
Capital Stock
0.00
+33.33%
0.00
+50.00%
0.00
+100.00%
0.00
Common Stock
0.00
+33.33%
0.00
+50.00%
0.00
+100.00%
0.00
Share Issued
43.53
+63.59%
26.61
+21.84%
21.84
+162.17%
8.33
Ordinary Shares Number
43.53
+63.59%
26.61
+21.84%
21.84
+162.17%
8.33
Additional Paid In Capital
357.49
+23.45%
289.59
+10.95%
261.00
+19.19%
218.98
Retained Earnings
-302.29
-19.24%
-253.51
-14.45%
-221.50
-9.88%
-201.59
Total Equity Gross Minority Interest
55.20
+52.97%
36.09
-8.65%
39.50
+127.11%
17.39
Total Capitalization
55.20
+52.97%
36.09
-8.65%
39.50
+127.11%
17.39
Working Capital
50.76
+54.55%
32.84
-13.89%
38.14
+134.61%
16.26
Invested Capital
55.20
+52.97%
36.09
-8.65%
39.50
+127.11%
17.39
Total Debt
3.29
+40.72%
2.34
+46.58%
1.59
-1.18%
1.61
Capital Lease Obligations
3.29
+40.72%
2.34
+46.58%
1.59
-1.18%
1.61
Net Tangible Assets
55.20
+52.97%
36.09
-8.65%
39.50
+127.11%
17.39
Tangible Book Value
55.20
+52.97%
36.09
-8.65%
39.50
+127.11%
17.39
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-35.10
-60.52%
-21.87
-33.54%
-16.38
-5.37%
-15.54
Cash Flow From Continuing Operating Activities
-35.10
-60.52%
-21.87
-33.54%
-16.38
-5.37%
-15.54
Net Income From Continuing Operations
-48.79
-52.43%
-32.01
-60.70%
-19.92
-7.71%
-18.49
Depreciation Amortization Depletion
0.48
+70.00%
0.28
+20.69%
0.23
+23.40%
0.19
Depreciation
0.48
+70.00%
0.28
+20.69%
0.23
—
Depreciation And Amortization
0.48
+70.00%
0.28
+20.69%
0.23
+23.40%
0.19
Other Non Cash Items
0.42
+315.90%
-0.20
-167.01%
0.29
+554.69%
-0.06
Pension And Employee Benefit Expense
-0.28
-487.50%
0.07
-1.37%
0.07
-6.41%
0.08
Stock Based Compensation
12.33
+21.64%
10.14
+125.79%
4.49
+90.90%
2.35
Operating Gains Losses
-0.29
-506.94%
0.07
+7.46%
0.07
-14.10%
0.08
Unrealized Gain Loss On Investment Securities
-0.36
+59.84%
-0.89
-20.97%
-0.74
0.00
Gain Loss On Sale Of PPE
-0.01
0.00
+100.00%
-0.01
0.00
Change In Working Capital
1.11
+50.27%
0.74
+191.89%
-0.80
-302.78%
0.40
Change In Receivables
-0.31
-258.59%
0.20
+116.43%
-1.21
-948.59%
0.14
Changes In Account Receivables
-0.60
-356.90%
0.23
+130.13%
-0.77
-505.26%
0.19
Change In Inventory
-0.83
-78.02%
-0.46
+4.33%
-0.48
-1.46%
-0.48
Change In Prepaid Assets
-0.24
+51.04%
-0.48
-725.97%
0.08
+1000.00%
0.01
Change In Payables And Accrued Expense
2.48
+67.25%
1.48
+82.76%
0.81
+12.15%
0.72
Change In Payable
2.48
+67.25%
1.48
+82.76%
0.81
+12.15%
0.72
Change In Account Payable
0.00
-99.68%
0.32
+12.50%
0.28
+219.66%
-0.23
Change In Other Working Capital
—
—
—
—
Investing Cash Flow
-30.56
-341.75%
12.64
+178.55%
-16.09
-290.64%
8.44
Cash Flow From Continuing Investing Activities
-30.56
-341.75%
12.64
+178.55%
-16.09
-290.64%
8.44
Net PPE Purchase And Sale
-1.65
-17.48%
-1.40
-279.95%
-0.37
+21.99%
-0.47
Purchase Of PPE
-1.66
-18.54%
-1.40
-267.98%
-0.38
+19.45%
-0.47
Sale Of PPE
0.01
0.00
-100.00%
0.01
0.00
Capital Expenditure
-1.66
-18.54%
-1.40
-267.98%
-0.38
+19.45%
-0.47
Net Investment Purchase And Sale
-29.19
-306.60%
14.13
+190.32%
-15.64
-273.82%
9.00
Purchase Of Investment
-56.84
-282.25%
-14.87
+62.96%
-40.14
-111.28%
-19.00
Sale Of Investment
27.65
-4.66%
29.00
+18.37%
24.50
-12.50%
28.00
Net Other Investing Changes
0.28
+420.69%
-0.09
-10.13%
-0.08
+8.14%
-0.09
Financing Cash Flow
55.57
+201.15%
18.45
-50.84%
37.53
+26910.00%
-0.14
Cash Flow From Continuing Financing Activities
55.57
+201.15%
18.45
-50.84%
37.53
+26910.00%
-0.14
Net Common Stock Issuance
38.71
+2322.65%
1.60
-95.74%
37.53
0.00
Proceeds From Stock Option Exercised
16.86
+0.01%
16.85
0.00
—
Net Other Financing Charges
—
—
—
-0.14
Changes In Cash
-10.09
-209.42%
9.22
+82.10%
5.07
+169.96%
-7.24
Effect Of Exchange Rate Changes
0.12
+129.41%
0.05
+187.93%
-0.06
+55.73%
-0.13
Beginning Cash Position
18.92
+96.22%
9.64
+108.12%
4.63
-61.41%
12.00
End Cash Position
8.94
-52.74%
18.92
+96.22%
9.64
+108.12%
4.63
Free Cash Flow
-36.77
-57.99%
-23.27
-38.87%
-16.76
-4.63%
-16.02
Common Stock Issuance
38.71
+2322.65%
1.60
-95.74%
37.53
0.00
Issuance Of Capital Stock
38.71
+2322.65%
1.60
-95.74%
37.53
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category